Published in Mol Cancer on March 04, 2010
SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J Biol Chem (2010) 1.05
The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy. Mol Cancer (2014) 0.91
Regulation of Interferon-Stimulated Gene BST2 by a lncRNA Transcribed from a Shared Bidirectional Promoter. Front Immunol (2015) 0.90
Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. J Biol Chem (2010) 0.89
High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem (2012) 0.87
FH535 inhibited metastasis and growth of pancreatic cancer cells. Onco Targets Ther (2015) 0.81
Xenopus laevis zygote arrest 2 (zar2) encodes a zinc finger RNA-binding protein that binds to the translational control sequence in the maternal Wee1 mRNA and regulates translation. Dev Biol (2012) 0.81
Zar1 represses translation in Xenopus oocytes and binds to the TCS in maternal mRNAs with different characteristics than Zar2. Biochim Biophys Acta (2013) 0.81
Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65. J Biomed Sci (2013) 0.80
Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture. PLoS One (2016) 0.75
Reduced canine BRCA2 expression levels in mammary gland tumors. BMC Vet Res (2015) 0.75
A unified set-based test with adaptive filtering for gene-environment interaction analyses. Biometrics (2015) 0.75
An abundance of bidirectional promoters in the human genome. Genome Res (2004) 5.90
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
Bidirectional gene organization: a common architectural feature of the human genome. Cell (2002) 3.47
Control of eukaryotic protein synthesis by upstream open reading frames in the 5'-untranslated region of an mRNA. Biochem J (2002) 2.73
Pancreatic carcinogenesis. Pancreatology (2008) 2.60
GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol (2005) 2.55
Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet (2008) 1.96
Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans (2006) 1.82
Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res (2009) 1.79
Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol (2009) 1.77
Comprehensive annotation of bidirectional promoters identifies co-regulation among breast and ovarian cancer genes. PLoS Comput Biol (2007) 1.69
Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res (2008) 1.59
Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. J Biol Chem (2005) 1.39
Breast cancer genes--what are the real risks? Nat Genet (1997) 1.38
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. Br J Cancer (2007) 1.38
Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair (Amst) (2008) 1.29
The molecular pathology of hereditary breast cancer. Pathobiology (2008) 1.25
Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther (2006) 1.22
Hereditary ovarian cancer. Hum Pathol (2005) 1.21
Alternative initiation and splicing in dicer gene expression in human breast cells. Breast Cancer Res (2005) 1.20
Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res (1997) 1.17
Trypanosoma brucei BRCA2 acts in antigenic variation and has undergone a recent expansion in BRC repeat number that is important during homologous recombination. Mol Microbiol (2008) 1.15
Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer. Clin Cancer Res (2007) 1.09
In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun (2008) 1.02
GATA4 mediates gene repression in the mature mouse small intestine through interactions with friend of GATA (FOG) cofactors. Dev Biol (2008) 1.02
p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage. J Biol Chem (2003) 0.97
Isolation and initial characterization of the BRCA2 promoter. Oncogene (1999) 0.96
Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene (2007) 0.96
Induction of the BRCA2 promoter by nuclear factor-kappa B. J Biol Chem (2000) 0.96
Inhibition of cancer cell growth by BRCA2. Cancer Res (2002) 0.93
Transcriptional gene silencing by short interfering RNAs. Curr Opin Mol Ther (2005) 0.92
Identification and characterization of a transcriptional silencer upstream of the human BRCA2 gene. Biochem Biophys Res Commun (1999) 0.92
Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism. Breast Cancer Res (2007) 0.89
Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter. J Biol Chem (2008) 0.88
BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res (2005) 0.87
Role of Blm and collaborating factors in recombination and survival following replication stress in Ustilago maydis. DNA Repair (Amst) (2009) 0.87
Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression. Oncogene (1998) 0.85
Essential role of brc-2 in chromosome integrity of germ cells in C. elegans. Mol Cells (2008) 0.81
Expression cloning of Xenopus zygote arrest 2 (Xzar2) as a novel epidermalization-promoting factor in early embryos of Xenopus laevis. Genes Cells (2009) 0.80
A putative protein structurally related to zygote arrest 1 (Zar1), Zar1-like, is encoded by a novel gene conserved in the vertebrate lineage. Comp Biochem Physiol B Biochem Mol Biol (2008) 0.80
Molecular characterization of a human BRCA2 homolog in Leishmania donovani. J Parasitol (2005) 0.78
Breast cancer and ovarian cancer genetics: an update. J Environ Pathol Toxicol Oncol (2008) 0.77
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest (2010) 4.70
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med (2013) 3.57
Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology (2008) 3.38
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell (2012) 2.81
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood (2011) 2.07
Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity (2006) 1.95
Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation (2002) 1.55
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J Exp Med (2011) 1.45
Regulation of BRCA2 gene expression by the SLUG repressor protein in human breast cells. J Biol Chem (2005) 1.39
Yeast TFIID serves as a coactivator for Rap1p by direct protein-protein interaction. Mol Cell Biol (2006) 1.31
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood (2013) 1.28
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23
Alternative initiation and splicing in dicer gene expression in human breast cells. Breast Cancer Res (2005) 1.20
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins. Proc Natl Acad Sci U S A (2013) 1.19
Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. Cancer Res (2007) 1.19
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19
Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. Cancer Res (2003) 1.12
TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation. Nature (2010) 1.12
MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res (2003) 1.11
Negative regulation of the expressions of cytokeratins 8 and 19 by SLUG repressor protein in human breast cells. Biochem Biophys Res Commun (2005) 1.07
SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J Biol Chem (2010) 1.05
Cystatin superfamily. J Health Care Poor Underserved (2010) 1.05
In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun (2008) 1.02
A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors. Cancer Res (2010) 1.02
Mapping the initiator binding Taf2 subunit in the structure of hydrated yeast TFIID. Structure (2009) 1.01
Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J (2011) 0.99
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Blood (2011) 0.98
Downregulation of mitochondrial porin inhibits cell growth and alters respiratory phenotype in Trypanosoma brucei. Eukaryot Cell (2009) 0.95
Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci U S A (2002) 0.95
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis. Cancer Res (2013) 0.94
Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations. Blood (2014) 0.94
17-epiestriol, an estrogen metabolite, is more potent than estradiol in inhibiting vascular cell adhesion molecule 1 (VCAM-1) mRNA expression. J Biol Chem (2003) 0.93
Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy. PLoS One (2013) 0.91
Down-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cells. Biochem Biophys Res Commun (2005) 0.91
Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithine. J Biol Chem (2002) 0.90
Regulation of nitric oxide consumption by hypoxic red blood cells. Proc Natl Acad Sci U S A (2003) 0.89
ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy. PLoS One (2009) 0.89
Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. J Biol Chem (2010) 0.89
Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages. J Biol Chem (2005) 0.88
Human SLUG does not directly bind to CtBP1. Biochem Biophys Res Commun (2006) 0.88
Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario. J Interferon Cytokine Res (2014) 0.88
Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice. J Neurosci Res (2010) 0.88
Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism. Proc Natl Acad Sci U S A (2006) 0.87
High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem (2012) 0.87
Maintenance of higher H₂O₂ levels, and its mechanism of action to induce growth in breast cancer cells: important roles of bioactive catalase and PP2A. Free Radic Biol Med (2012) 0.86
Mitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: implications for breast cancer. Free Radic Biol Med (2012) 0.85
Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status. Fertil Steril (2003) 0.85
Protein translocase of mitochondrial inner membrane in Trypanosoma brucei. J Biol Chem (2012) 0.85
Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure. Hepatology (2015) 0.83
NO to breast: when, why and why not? Curr Pharm Des (2010) 0.83
Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis. Cancer Res (2008) 0.83
Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. Synapse (2013) 0.83
Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. Mol Cancer Res (2012) 0.83
Nitric oxide, N omega-hydroxy-L-arginine and breast cancer. Nitric Oxide (2008) 0.83
Proteomic identification of mitochondrial targets of arginase in human breast cancer. PLoS One (2013) 0.83
Inactivation of a gene for a fibronectin-binding protein of the oral bacterium Streptococcus mutans partially impairs its adherence to fibronectin. Microb Pathog (2008) 0.83
Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women: implications in atherosclerosis. Fertil Steril (2005) 0.81
Serum levels of soluble vascular cell adhesion molecule-1, tumor necrosis factor-alpha, and interleukin-6 in in vitro fertilization cycles. Fertil Steril (2008) 0.80
Gestational diabetes, preeclampsia and cytokine release: similarities and differences in endothelial cell function. Adv Exp Med Biol (2014) 0.79
Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. Mol Biol Rep (2009) 0.78
Molecular characterization of a human BRCA2 homolog in Leishmania donovani. J Parasitol (2005) 0.78
Protein phosphatase 2A promotes endothelial survival via stabilization of translational inhibitor 4E-BP1 following exposure to tumor necrosis factor-α. Arterioscler Thromb Vasc Biol (2011) 0.77
Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages. Mol Cell Biochem (2010) 0.77
Peptide aptamer mimicking RAD51-binding domain of BRCA2 inhibits DNA damage repair and survival in Trypanosoma brucei. Microb Pathog (2011) 0.76
Induction of a feed forward pro-apoptotic mechanistic loop by nitric oxide in a human breast cancer model. PLoS One (2013) 0.76
A type II ribonuclease H from Leishmania mitochondria: an enzyme essential for the growth of the parasite. Mol Biochem Parasitol (2005) 0.76
A light-activated NO donor attenuates anchorage independent growth of cancer cells: Important role of a cross talk between NO and other reactive oxygen species. Arch Biochem Biophys (2013) 0.76
Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in younger women. Fertil Steril (2004) 0.76
A past medical history of gestational diabetes: its medical significance and its dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 0.75
Endothelial cell function in utero-placental circulation physiology and pathophysiology. Curr Vasc Pharmacol (2013) 0.75
Study of Carnitine/Acylcarnitine and Aminoacid Profile in children and adults with Acute Liver Failure. J Pediatr Gastroenterol Nutr (2016) 0.75
A multimodality approach to reversible paraneoplastic encephalitis associated with ovarian teratomas. Acta Oncol (2009) 0.75
Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens. J Pediatr Hematol Oncol (2017) 0.75
Procoagulant abnormalities in cirrhosis with portal vein thrombosis. Indian J Gastroenterol (2014) 0.75
Identification and full-length molecular characterization of rare hepatitis C virus genotype 5a from India. Arch Virol (2014) 0.75